Key Points for Storage Quality Control and Lot-to-Lot Consistency Management of Flow Cytometry Antibodies

Storage Conditions and Handling Guidelines

The activity and stability of flow cytometry antibody products are highly dependent on storage conditions. Antibodies in common formats are generally recommended to be stored at 2 to 8°C protected from light, and some products containing fluorophores are more sensitive to repeated warming and light exposure. Upon arrival, the storage requirements in the product instructions should be verified as soon as possible, and the product should be stored at the recommended temperature. For long-term storage, frequent removal from the refrigerator should be avoided to reduce the impact of temperature fluctuations on protein structure and fluorescent labeling. For antibodies containing preservatives such as sodium azide, attention should be paid to their compatibility with live-cell functional assays during use.

When handling antibodies, it is recommended to operate in a clean environment, use sterile tips, and avoid cross-contamination. After opening the cap, it should be tightly closed as soon as possible to prevent evaporation or microbial contamination. If the antibody solution shows visible precipitate, turbidity, or abnormal color change, use should be suspended and performance verification should be conducted. Recording the opening date and number of uses routinely helps evaluate the stability of the remaining reagent.

Avoid Repeated Freeze-Thaw Cycles and Aliquotting Recommendations

Flow cytometry antibodies are usually stored in liquid form, and repeated freeze-thaw cycles may cause antibody aggregation, fluorophore dissociation, or decreased activity. For large-package products, it is recommended to aliquot into small volumes based on common experimental usage at the time of first use to reduce subsequent repeated thawing. Aliquot containers should be made of low-protein-binding material and clearly labeled with product name, clone number, lot number, and aliquotting date. During aliquotting, the generation of bubbles should be minimized to prevent protein denaturation.

Antibodies with different fluorescent labels differ in their tolerance to freeze-thaw cycles, and tandem dyes require particular attention. If the antibody product itself contains stabilizers or protective proteins, it can usually be aliquoted as the stock solution; if diluted in-house, it is necessary to confirm compatibility between the diluent and the antibody and avoid long-term storage of diluted working solutions. In general, it is recommended that working solutions be prepared fresh immediately before use, and that stock solutions be stored under the recommended conditions to ensure consistent staining intensity across experiments.

Lot-to-Lot Consistency Assessment

As biological products, antibodies may show slight fluctuations in protein concentration, conjugation ratio, or fluorescence intensity between different lots. For projects requiring long-term data accumulation or multicenter collaboration, lot-to-lot consistency management is particularly important. Before introducing a new lot, it is recommended to perform parallel staining with the same positive sample alongside the current lot and compare the positive percentage, mean fluorescence intensity, and background signal. If the data deviation between the two lots is within an acceptable range, they can be considered consistent; if the difference is significant, the amount used should be adjusted or the supplier should be contacted for confirmation.

When switching lots, reference samples or data records of key flow cytometry antibodies should be retained for subsequent tracking. For critical population-discriminating antibodies, internal reference standards can be established, and quality control testing can be performed regularly using the same cell line or cryopreserved peripheral blood mononuclear cells. This can not only reveal lot differences but also monitor the potential impact of instrument drift or changes in the staining workflow on results.

Routine Quality Control and Record Management

Continuous routine quality control is the foundation for maintaining stable performance of flow cytometry antibody products. Laboratories can establish a simple quality control workflow, including instrument optical path calibration for each experiment, recording fluorescence intensity of single-stain controls, and repeated testing of positive samples. For key antibodies in multicolor panels, the same reference sample can be used consistently to set gates and observe trends in gate boundaries and positive percentages across different experiments.

Record management should cover information such as antibody name, clone number, fluorophore, lot number, arrival date, opening date, storage location, and usage log. Electronic records or paper forms are both acceptable; the key is to ensure traceability of information. When abnormal experimental results occur, complete records can help quickly identify the cause, whether it is antibody failure, improper sample handling, or instrument setting deviation. Standardized management can not only extend the effective service life of flow cytometry antibody products but also help improve the reliability and reproducibility of experimental data.